SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Bookmark and Share
Biotech Bay
Genentech (South SF) Puts Words In The Mouths Of Politicians
November 17, 2009
 · 
1 min read
Bookmark and Share
BioMidwest
Genentech, Inc.'s Hedgehog Drug Helps Late-Stage Cancers, Johns Hopkins University, Karmanos Cancer Institute And Translational Genomics Research Institute (TGen) Study
September 3, 2009
 · 
1 min read
Deals
Genentech, Inc.'s Levinson May Have No Change-of-Control Agreement in Roche Deal
March 13, 2009
 · 
1 min read
Biogen Idec, Inc. (California) And Genentech, Inc.'s Rituxan Can Cut Kidney Inflammation In Lupus, Imperial College London Study
March 5, 2009
 · 
1 min read
Biotech Bay
Another Possible Alzheimer’s Culprit Found, Genentech, Inc. And Salk Institute for Biological Studies Study
February 19, 2009
 · 
1 min read
Drug Development
Genentech, Inc. And Biogen Idec, Inc. (California)'s Rituximab Maintenance Therapy Improves Survival In Patients With Relapsed Follicular Lymphoma, Rabin Medical Center (Beilinson Hospital) Study
February 11, 2009
 · 
1 min read
REACH Call and Genentech, Inc. Provide Stroke Education to Telestroke Customers
January 26, 2009
 · 
1 min read
Biotech Bay
University of California, San Diego (UCSD) and Genentech, Inc. Scientists Develop Potentially Disruptive Antibody Sequencing Technology
December 19, 2008
 · 
1 min read
Biotech Bay
Genentech, Inc. Scientists Grow Mouse Prostate From A Single Cell
October 23, 2008
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
June 30, 2026
 · 
10 min read
Press Releases
FDA Approves First Single-Dose Generic Treatment for Influenza
June 18, 2026
 · 
2 min read
Press Releases
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
June 11, 2026
 · 
14 min read
Press Releases
FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting
June 2, 2026
 · 
7 min read
Press Releases
Genentech to Present New Data Advancing Its Obesity Portfolio at the American Diabetes Association’s 2026 Scientific Sessions
June 1, 2026
 · 
6 min read
Press Releases
Lupus Research Alliance and Genentech Fund Researchers Translating CAR T Success into Durable Lupus Treatments
May 26, 2026
 · 
5 min read
Press Releases
Genentech to Present New Data at ASCO 2026, Reinforcing Giredestrant’s Potential to Transform the Treatment Paradigm in Early Breast Cancer
May 19, 2026
 · 
19 min read
Press Releases
Roche to present new data at ASCO 2026, reinforcing giredestrant’s potential to transform the treatment paradigm in early breast cancer
May 19, 2026
 · 
12 min read
Press Releases
FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
May 17, 2026
 · 
10 min read
Press Releases
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026
 · 
15 min read
Load More